A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05176639 |
Recruitment Status :
Active, not recruiting
First Posted : January 4, 2022
Last Update Posted : May 9, 2024
|
Sponsor:
Viridian Therapeutics, Inc.
Information provided by (Responsible Party):
Viridian Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | July 2024 |
Estimated Study Completion Date : | March 2025 |